Loading…

Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer

Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is...

Full description

Saved in:
Bibliographic Details
Published in:Journal of dental anesthesia and pain medicine: JDAPM 2022, 22(2), , pp.129-143
Main Authors: Park, Jinsoo, Jung, Bongsu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c321t-2004f2368206b9447e2bf45ed329c54cf6d94c155056b071645744eb7a6be9263
container_end_page 143
container_issue 2
container_start_page 129
container_title Journal of dental anesthesia and pain medicine: JDAPM
container_volume 22
creator Park, Jinsoo
Jung, Bongsu
description Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps. We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested. The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level. PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump.
doi_str_mv 10.17245/jdapm.2022.22.2.129
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9942582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2654282857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-2004f2368206b9447e2bf45ed329c54cf6d94c155056b071645744eb7a6be9263</originalsourceid><addsrcrecordid>eNpVUl1r1TAYLqK4MfcPRHKpFz2m-WibG2GMOQcDReZ1SNO3O9mSpibpkeMP8fcu7ZkHhTe8gTwfyZunKN5WeFM1hPGPD72a3IZgQjZLbSoiXhSnhLa0FLRqXh73WJwU5zE-YIwzk2KCXxcnlDMmmpadFn--QRh8cGrUgGCn7KyS8SOKae73yA9IIe2dg6CNsnaP1E4ZqzoLKDoVEpoyHMZUaj-m4K2FHqlR2XuIRqFpdhP6ZdIWpS0gZ3TwnbKrlYO09Qt2WciMwxwX24W7_w3hTfFqUDbC-XM_K358vrq7_FLefr2-uby4LTUlVSoJxmwgtG4JrjvBWAOkGxiHnhKhOdND3QumK84xrzvcVDXjDWPQNaruQJCanhUfDrpjGOSjNtIrs_Z7Lx-DvPh-dyOFYIS3JGM_HbDT3DnodX52UFZOweRJ7Ffm_yej2WadnWyF4HVDs8D7Z4Hgf84Qk3QmarB5IuDnKEnNGWlJy5sMZQdoHlmMAYajTYXlmgC5JkAuCZBLyZyATHv37xWPpL__TZ8A7-axVw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2654282857</pqid></control><display><type>article</type><title>Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer</title><source>PubMed</source><creator>Park, Jinsoo ; Jung, Bongsu</creator><creatorcontrib>Park, Jinsoo ; Jung, Bongsu</creatorcontrib><description>Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps. We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested. The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level. PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump.</description><identifier>ISSN: 2383-9309</identifier><identifier>EISSN: 2383-9317</identifier><identifier>DOI: 10.17245/jdapm.2022.22.2.129</identifier><identifier>PMID: 35449784</identifier><language>eng</language><publisher>Korea (South): The Korean Dental Society of Anesthsiology</publisher><subject>Original ; 치의학</subject><ispartof>Journal of Dental Anesthesia and Pain Medicine, 2022, 22(2), , pp.129-143</ispartof><rights>Copyright © 2022 Journal of Dental Anesthesia and Pain Medicine.</rights><rights>Copyright © 2022 Journal of Dental Anesthesia and Pain Medicine 2022 Journal of Dental Anesthesia and Pain Medicine</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c321t-2004f2368206b9447e2bf45ed329c54cf6d94c155056b071645744eb7a6be9263</cites><orcidid>0000-0002-7160-5379 ; 0000-0002-1994-9975</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995673/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995673/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35449784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002823064$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Park, Jinsoo</creatorcontrib><creatorcontrib>Jung, Bongsu</creatorcontrib><title>Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer</title><title>Journal of dental anesthesia and pain medicine: JDAPM</title><addtitle>J Dent Anesth Pain Med</addtitle><description>Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps. We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested. The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level. PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump.</description><subject>Original</subject><subject>치의학</subject><issn>2383-9309</issn><issn>2383-9317</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVUl1r1TAYLqK4MfcPRHKpFz2m-WibG2GMOQcDReZ1SNO3O9mSpibpkeMP8fcu7ZkHhTe8gTwfyZunKN5WeFM1hPGPD72a3IZgQjZLbSoiXhSnhLa0FLRqXh73WJwU5zE-YIwzk2KCXxcnlDMmmpadFn--QRh8cGrUgGCn7KyS8SOKae73yA9IIe2dg6CNsnaP1E4ZqzoLKDoVEpoyHMZUaj-m4K2FHqlR2XuIRqFpdhP6ZdIWpS0gZ3TwnbKrlYO09Qt2WciMwxwX24W7_w3hTfFqUDbC-XM_K358vrq7_FLefr2-uby4LTUlVSoJxmwgtG4JrjvBWAOkGxiHnhKhOdND3QumK84xrzvcVDXjDWPQNaruQJCanhUfDrpjGOSjNtIrs_Z7Lx-DvPh-dyOFYIS3JGM_HbDT3DnodX52UFZOweRJ7Ffm_yej2WadnWyF4HVDs8D7Z4Hgf84Qk3QmarB5IuDnKEnNGWlJy5sMZQdoHlmMAYajTYXlmgC5JkAuCZBLyZyATHv37xWPpL__TZ8A7-axVw</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Park, Jinsoo</creator><creator>Jung, Bongsu</creator><general>The Korean Dental Society of Anesthsiology</general><general>대한치과마취과학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0002-7160-5379</orcidid><orcidid>https://orcid.org/0000-0002-1994-9975</orcidid></search><sort><creationdate>20220401</creationdate><title>Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer</title><author>Park, Jinsoo ; Jung, Bongsu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-2004f2368206b9447e2bf45ed329c54cf6d94c155056b071645744eb7a6be9263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Original</topic><topic>치의학</topic><toplevel>online_resources</toplevel><creatorcontrib>Park, Jinsoo</creatorcontrib><creatorcontrib>Jung, Bongsu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Journal of dental anesthesia and pain medicine: JDAPM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Jinsoo</au><au>Jung, Bongsu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer</atitle><jtitle>Journal of dental anesthesia and pain medicine: JDAPM</jtitle><addtitle>J Dent Anesth Pain Med</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>22</volume><issue>2</issue><spage>129</spage><epage>143</epage><pages>129-143</pages><issn>2383-9309</issn><eissn>2383-9317</eissn><abstract>Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps. We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested. The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level. PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump.</abstract><cop>Korea (South)</cop><pub>The Korean Dental Society of Anesthsiology</pub><pmid>35449784</pmid><doi>10.17245/jdapm.2022.22.2.129</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-7160-5379</orcidid><orcidid>https://orcid.org/0000-0002-1994-9975</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2383-9309
ispartof Journal of Dental Anesthesia and Pain Medicine, 2022, 22(2), , pp.129-143
issn 2383-9309
2383-9317
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_9942582
source PubMed
subjects Original
치의학
title Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A21%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Performance%20evaluation%20study%20of%20a%20commercially%20available%20smart%20patient-controlled%20analgesia%20pump%20with%20the%20microbalance%20method%20and%20an%20infusion%20analyzer&rft.jtitle=Journal%20of%20dental%20anesthesia%20and%20pain%20medicine:%20JDAPM&rft.au=Park,%20Jinsoo&rft.date=2022-04-01&rft.volume=22&rft.issue=2&rft.spage=129&rft.epage=143&rft.pages=129-143&rft.issn=2383-9309&rft.eissn=2383-9317&rft_id=info:doi/10.17245/jdapm.2022.22.2.129&rft_dat=%3Cproquest_nrf_k%3E2654282857%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c321t-2004f2368206b9447e2bf45ed329c54cf6d94c155056b071645744eb7a6be9263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2654282857&rft_id=info:pmid/35449784&rfr_iscdi=true